Researchers study how patients do after lung transplant

NewsGuard 100/100 Score

In the past five years, the number of lung transplantations carried out has increased by about 20%. In the end stage of various lung diseases, transplantation is the last remaining option for treatment, and it can both prolong life and improve its quality. Marc Hartert and colleagues have studied how patients do after a lung transplant, and their review appears in the current edition of the Deutsches -rzteblatt International (Dtsch Arztebl Int 2014; 111(7): 107-16).

What they found is that deaths in the 90 days after an operation for lung transplantation have gone down over the past 25 years from 19.4% to 10%. Although this is a positive finding, many patients still struggle with serious complications: about 3% have an acute transplant rejection reaction, while almost 30% experience symptoms of chronic rejection. Other frequently occurring problems are airway complications, transplant failure, and other serious medical conditions-often elsewhere in the body besides the lungs-resulting from the transplantation.

To continue to improve long-term results after lung transplantation, the authors suggest that better collaboration is needed between the transplantation centers and the local doctors and hospitals attended by patients for their ongoing aftercare.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Letermovir: A promising breakthrough in CMV prevention for kidney transplant recipients